Oseltamivir PK/PD Modeling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection.
about
Analysis of Practical Identifiability of a Viral Infection ModelHierarchical effects of pro-inflammatory cytokines on the post-influenza susceptibility to pneumococcal coinfection.Mechanisms of Severe Mortality-Associated Bacterial Co-infections Following Influenza Virus Infection.Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms.Influenza interaction with cocirculating pathogens and its impact on surveillance, pathogenesis, and epidemic profile: A key role for mathematical modelling.
P2860
Oseltamivir PK/PD Modeling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Oseltamivir PK/PD Modeling and ...... enza-Pneumococcus Coinfection.
@ast
Oseltamivir PK/PD Modeling and ...... enza-Pneumococcus Coinfection.
@en
type
label
Oseltamivir PK/PD Modeling and ...... enza-Pneumococcus Coinfection.
@ast
Oseltamivir PK/PD Modeling and ...... enza-Pneumococcus Coinfection.
@en
prefLabel
Oseltamivir PK/PD Modeling and ...... enza-Pneumococcus Coinfection.
@ast
Oseltamivir PK/PD Modeling and ...... enza-Pneumococcus Coinfection.
@en
P2093
P2860
P356
P1476
Oseltamivir PK/PD Modeling and ...... uenza-Pneumococcus Coinfection
@en
P2093
Alessandro Boianelli
Dunja Bruder
Niharika Sharma-Chawla
P2860
P356
10.3389/FCIMB.2016.00060
P577
2016-06-14T00:00:00Z